静脈内（IV）治療と静脈アクセスの世界市場

Report Highlights

The global market for IV therapy and venous access devices is expected to grow from $57.0 billion in 2024 and is projected to reach $74.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2024 to 2029.

静脈内（IV）治療および静脈アクセス デバイスの世界市場は、2024 年の 570 億ドルから 2024 年から 2029 年の予測期間中に 5.5% の複合年間成長率 (CAGR) で成長し、2029 年末までに 744 億ドルに達すると予測されています。

Report Scope

This report examines the global market for IV therapy and venous access devices, providing a comprehensive review of applications across several healthcare facility settings.

The study covers a range of IV solutions and devices used in therapeutic applications. BCC Research has analyzed critical market components, including types of IV solutions. These include general IV solutions, parenteral nutrition IV solutions and premixed drug IV solutions; infusion pumps such as general infusion pumps, specialized infusion pumps, portable and disposable infusion pumps, and implantable infusion pumps; and venous access devices such as peripheral IV catheters and central venous catheters.

– Products for each IV solution and set market segment include:

– General IV solutions and sets: Includes normal saline, hypertonic saline, Lactated Ringer’s, Dextran and dextrose in water, along with IV sets, containers and accessories for care settings.

– Parenteral nutrition IV solutions and sets: Covers nutrient-rich solutions (carbohydrates, lipid emulsions, amino acids, trace elements, vitamins, minerals) with accompanying IV sets and accessories for care settings.

– Premixed IV solutions and sets: Includes premixed drugs (antibiotics, pain management, cardiovascular agents) with drug-delivery systems, containers, and accessories for care settings.

This report addresses regulatory aspects, including technological advances (patents and approvals), and the latest trends, preferences and developments in IV therapy. It includes market projections and market share analysis for global IV therapy and venous access market. It covers emerging technologies, such as AI-integrated ultrasonography for automatic vein measurement to prevent IV catheter failure, and AI-enabled, ultrasound-guided handheld robotic devices for femoral vascular. The market is segmented by region into North America, Asia-Pacific, Europe, and Rest of the World (RoW), and analyzes the markets for the U.S., Canada, Mexico, France, Germany, the U.K., Italy, Spain, Japan, India, Australia, South Korea and China.

Report Synopsis

Report Includes

– 92 data tables and 53 additional tables

– Analyses of the global market trends for intravenous (IV) therapy and vein access devices, with revenue data (sales figures) from 2021-2023, forecasts for 2024, and projected CAGRs through 2029

– Estimates of the market size and revenue prospects, along with a corresponding market share analysis by product type, application, end user and region

– Discussion of the market potential and opportunities in the medical device industry, along with an analysis of the competitive environment, regulatory scenario, and technological advances

– Facts and figures pertaining to R&D activity, industry-specific challenges, and the impact of macroeconomic factors

– Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses

– Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies

– Patent analysis featuring key granted and published patents

– Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook

– Company profiles, including BD, B. Braun, Fresenius SE & Co. KGaA, Baxter, and Medtronic

Table of Contents

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Market Summary

Chapter 2 Market Overview

Market Definition

IV Therapy Overview

Human Circulatory System

Definition of Infusion Therapy

Definition of IV Therapy

Methods of IV Infusion Pump

Pump Infusion

Drip Infusion

History of IV Therapy

IV Solutions

General IV Solutions

Parenteral Nutrition IV Solutions

Premixed Drug IV Solutions

IV Infusion Pumps

Venous Access Devices (IV Catheters)

Chapter 3 Market Dynamics

Overview

Market Drivers

Growing Aging Population Worldwide

Growing Prevalence of Chronic Diseases

Expectations for Increased Quality of Care

Alternative Site and Home-based Medical Care

Global Burden of VTE and Hospital-Acquired Infections

Market Restraints

Risk of Infections and Complications

Reimbursement Policies

Market Opportunities

Technological Advances

Growing Healthcare Spending in Emerging Markets

Market Challenges

Regulatory Challenges

Safety Issues and Recalls

Chapter 4 Market Segment Analysis

Overview

Segmentation Breakdown

Market Analysis by Product Type

IV Solutions and Sets

Infusion Pumps

Venous Access Devices (IV Catheters)

Market Analysis by Application

Market Size and Forecast

Hospitals

Alternative Care Settings

Home-based

Geographic Breakdown

Market Analysis by Region

North America

Europe

Asia-Pacific

Rest of the World

Chapter 5 Emerging Trends and Technologies

Overview

Advances in Intraosseous Infusion Systems for Vascular Access

Antimicrobial-Coated Sets

Needleless Connectors

IV Filters

Smart Vein Visualization and Access Devices

Smart IV Devices

Blood Transfusion Sets

Wireless Sensor Networks and AI in IV Therapy

Advances in IV Therapy and Venous Access

Chapter 6 ESG Developments

ESG in the IV Therapy and Venous Access Industry

ESG Sustainability of Major Manufacturers

ESG Risk Ratings

BCC Research Viewpoint

Chapter 7 Patent Analysis

IV Therapy and Venous Access Patents

Chapter 8 Competitive Landscape

Analysis of Leading Companies’ Market Shares

Startups and Other Interesting Companies

Mergers, Acquisitions and Collaborations

Strategic Alliances

Chapter 9 Appendix

Methodology

Sources

Abbreviations

Company Profiles

ANGIODYNAMICS

BAXTER

• BRAUN SE

BD

CARDINAL HEALTH

COOK

FRESENIUS SE & CO. KGAA

ICU MEDICAL INC.

INTEGRATED MEDICAL SYSTEMS INC.

IRADIMED CORP.

MEDTRONIC

PFIZER INC.

TERUMO CORP.

VYGON SAS

WELLMED INTERNATIONAL INDUSTRIES PVT. LTD.

List of Tables

Summary Table : Global Market for IV Therapy and Venous Access Devices, by Product Type, Through 2029

Table 1 : History of IV Therapy, 1628-2007

Table 2 : Common Examples of General IV Solutions

Table 3 : Number and Percentage of People 65 and over, by Development Group, 2023 and 2050

Table 4 : Number of Persons 65 and over, by WHO Region, 2019 and 2050

Table 5 : Projected Number of U.S. Adults 50 and Older with One or More Chronic Condition, 2020–2050

Table 6 : Major Recalled Products in 2023, FDA

Table 7 : Global Market for IV Therapy and Venous Access Devices, by Product Type, Through 2029

Table 8 : Global Market for IV Solutions and Sets, by Region, Through 2029

Table 9 : Global Market for IV Solutions and Sets, by Type, Through 2029

Table 10 : Global Market for General IV Solutions and Sets, by Region, Through 2029

Table 11 : Global Market for Parenteral Nutrition IV Solutions and Sets, by Region, Through 2029

Table 12 : Global Market for Premixed Drug IV Solutions, by Region, Through 2029

Table 13 : Global Market for Other IV Solutions and Sets, by Region, Through 2029

Table 14 : Global Market for Infusion Pumps, by Region, Through 2029

Table 15 : Global Market for Infusion Pumps, by Type, Through 2029

Table 16 : Global Market for General Infusion Pumps, by Region, Through 2029

Table 17 : Global Market for Specialized Infusion Pumps, by Region, Through 2029

Table 18 : Global Market for Portable and Disposable Infusion Pumps, by Region, Through 2029

Table 19 : Global Market for Implantable Infusion Pumps, by Region, Through 2029

Table 20 : Global Market for Venous Access Devices (IV Catheters), by Region, Through 2029

Table 21 : Global Market for Venous Access Devices (IV Catheters), by Type, Through 2029

Table 22 : Global Market for PIVCs, by Region, Through 2029

Table 23 : Global Market for CVCs, by Region, Through 2029

Table 24 : Global Market for IV Therapy and Venous Access, by Application, Through 2029

Table 25 : Global Market for Hospital-based IV Therapy and Venous Access Products, by Region, Through 2029

Table 26 : Barriers and Facilitators to the Uptake of IV Therapies in Ambulatory Patients, 2024

Table 27 : Global Market for IV Therapy and Venous Access Products for Use in Alternative Care Settings, by Region, Through 2029

Table 28 : Global Market for Home Healthcare-based IV Therapy and Venous Access Products, by Region, Through 2029

Table 29 : Global Market for IV Therapy and Venous Access Devices, by Region, Through 2029

Table 30 : North American Market for IV Therapy and Venous Access, by Product, Through 2029

Table 31 : North American Market for IV Solutions and Sets, by Type, Through 2029

Table 32 : North American Market for Infusion Pumps, by Type, Through 2029

Table 33 : North American Market for Venous Access Devices (IV Catheters), by Type, Through 2029

Table 34 : North American Market for IV Therapy and Venous Access, by Application, Through 2029

Table 35 : North American Market for IV Therapy and Venous Access, by Country, Through 2029

Table 36 : U.S. Market for IV Therapy and Venous Access, by Product, Through 2029

Table 37 : U.S. Market for IV Therapy and Venous Access, by Application, Through 2029

Table 38 : Canadian Market for IV Therapy and Venous Access, by Product, Through 2029

Table 39 : Canadian Market for IV Therapy and Venous Access, by Application, Through 2029

Table 40 : Mexican Market for IV Therapy and Venous Access, by Product, Through 2029

Table 41 : Mexican Market for IV Therapy and Venous Access, by Application, Through 2029

Table 42 : European Market for IV Therapy and Venous Access, by Product, Through 2029

Table 43 : European Market for IV Solutions and Sets, by Type, Through 2029

Table 44 : European Market for Infusion Pumps, by Type, Through 2029

Table 45 : European Market for Venous Access Devices (IV Catheters), by Type, Through 2029

Table 46 : European Market for IV Therapy and Venous Access, by Application, Through 2029

Table 47 : European Market for IV Therapy and Venous Access, by Country, Through 2029

Table 48 : U.K. Market for IV Therapy and Venous Access, by Product, Through 2029

Table 49 : U.K. Market for IV Therapy and Venous Access, by Application, Through 2029

Table 50 : French Market for IV Therapy and Venous Access, by Product, Through 2029

Table 51 : French Market for IV Therapy and Venous Access, by Application, Through 2029

Table 52 : Italian Market for IV Therapy and Venous Access, by Product, Through 2029

Table 53 : Italian Market for IV Therapy and Venous Access, by Application, Through 2029

Table 54 : Leading Causes of Germany’s Disease Burden, by DALYs (Level 3), 2022

Table 55 : German Market for IV Therapy and Venous Access, by Product, Through 2029

Table 56 : German Market for IV Therapy and Venous Access, by Application, Through 2029

Table 57 : Spanish Market for IV Therapy and Venous Access, by Product, Through 2029

Table 58 : Spanish Market for IV Therapy and Venous Access, by Application, Through 2029

Table 59 : Rest of European Market for IV Therapy and Venous Access, by Product, Through 2029

Table 60 : Rest of European Market for IV Therapy and Venous Access, by Application, Through 2029

Table 61 : Asia-Pacific Market for IV Therapy and Venous Access, by Product, Through 2029

Table 62 : Asia-Pacific Market for IV Solutions and Sets, by Type, Through 2029

Table 63 : Asia-Pacific Market for Infusion Pumps, by Type, Through 2029

Table 64 : Asia-Pacific Market for Venous Access Devices, by Type, Through 2029

Table 65 : Asia-Pacific Market for IV Therapy and Venous Access, by Application, Through 2029

Table 66 : Asia-Pacific Market for IV Therapy and Venous Access, by Country, Through 2029

Table 67 : Chinese Market for IV Therapy and Venous Access, by Product, Through 2029

Table 68 : Chinese Market for IV Therapy and Venous Access, by Application, Through 2029

Table 69 : Indian Market for IV Therapy and Venous Access, by Product, Through 2029

Table 70 : Indian Market for IV Therapy and Venous Access, by Application, Through 2029

Table 71 : Japanese Market for IV Therapy and Venous Access, by Product, Through 2029

Table 72 : Japanese Market for IV Therapy and Venous Access, by Application, Through 2029

Table 73 : Approved Substitute Overseas-Registered IV Fluids Under Section 19A of the Therapeutic Goods Act 1989 for 2025

Table 74 : Australian Market for IV Therapy and Venous Access, by Product, Through 2029

Table 75 : Australian Market for IV Therapy and Venous Access, by Application, Through 2029

Table 76 : South Korean Market for IV Therapy and Venous Access, by Product, Through 2029

Table 77 : South Korean Market for IV Therapy and Venous Access, by Application, Through 2029

Table 78 : Rest of Asia-Pacific Market for IV Therapy and Venous Access, by Product, Through 2029

Table 79 : Rest of Asia-Pacific Market for IV Therapy and Venous Access, by Application, Through 2029

Table 80 : RoW Market for IV Therapy and Venous Access, by Product, Through 2029

Table 81 : RoW Market for IV Solutions and Sets, by Type, Through 2029

Table 82 : RoW Market for Infusion Pumps, by Type, Through 2029

Table 83 : RoW Market for Venous Access Devices, by Type, Through 2029

Table 84 : RoW Market for IV Therapy and Venous Access, by Application, Through 2029

Table 85 : ESG Steps Taken by Leading Companies, 2023

Table 86 : ESG Risk Rankings for IV Therapy and Venous Access Manufacturing Firm, 2023

Table 87 : Mergers and Acquisitions in the IV Therapy and Venous Access Industry, 2021–2024

Table 88 : Strategic Alliances in the IV Therapy and Venous Access Market, 2021–2024

Table 89 : Information Sources in this Report

Table 90 : Abbreviations Used in This Report

Table 91 : AngioDynamics: Company Snapshot

Table 92 : AngioDynamics: Financial Performance, FY 2022 and 2023

Table 93 : AngioDynamics: Product Portfolio

Table 94 : AngioDynamics: News/Key Developments, 2023 and 2024

Table 95 : Baxter: Company Snapshot

Table 96 : Baxter: Financial Performance, FY 2022 and 2023

Table 97 : Baxter: Product Portfolio

Table 98 : Baxter: News/Key Developments, 2024

Table 99 : B. Braun SE: Company Snapshot

Table 100 : B. Braun SE: Financial Performance, FY 2022 and 2023

Table 101 : B. Braun SE: Product Portfolio

Table 102 : B. Braun SE: News/Key Developments, 2022-2024

Table 103 : BD: Company Snapshot

Table 104 : BD: Financial Performance, FY 2023 and 2024

Table 105 : BD: Product Portfolio

Table 106 : BD: News/Key Developments, 2022–2024

Table 107 : Cardinal Health: Company Snapshot

Table 108 : Cardinal Health: Financial Performance, FY 2022 and 2023

Table 109 : Cardinal Health: Product Portfolio

Table 110 : Cardinal Health: News/Key Developments, 2024

Table 111 : Cook: Company Snapshot

Table 112 : Cook: Product Portfolio

Table 113 : Cook: News/Key Developments, 2024

Table 114 : Fresenius SE & Co. KGaA: Company Snapshot

Table 115 : Fresenius SE & Co. KGaA: Financial Performance, FY 2022 and 2023

Table 116 : Fresenius SE & Co. KGaA: Product Portfolio

Table 117 : Fresenius SE & Co. KGaA: News/Key Developments, 2023 and 2024

Table 118 : ICU Medical Inc.: Company Snapshot

Table 119 : ICU Medical Inc.: Financial Performance, FY 2022 and 2023

Table 120 : ICU Medical Inc.: Product Portfolio

Table 121 : ICU Medical Inc.: News/Key Developments, 2022-2024

Table 122 : Integrated Medical Systems Inc.: Company Snapshot

Table 123 : Integrated Medical System Inc.: Product Portfolio

Table 124 : Integrated Medical Systems Inc.: News/Key Developments, 2023 and 2024

Table 125 : IRadimed Corp.: Company Snapshot

Table 126 : IRadimed Corp.: Financial Performance, FY 2022 and 2023

Table 127 : IRadimed Corp.: Product portfolio

Table 128 : IRadimed Corp.: News/Key Developments, 2023

Table 129 : Medtronic: Company Snapshot

Table 130 : Medtronic: Financial Performance, FY 2022 and 2023

Table 131 : Medtronic: Product Portfolio

Table 132 : Medtronic: News/Key Developments, 2022 and 2023

Table 133 : Pfizer Inc.: Company Snapshot

Table 134 : Pfizer Inc.: Financial Performance, FY 2022 and 2023

Table 135 : Pfizer Inc.: Product Portfolio

Table 136 : Pfizer Inc.: News/Key Developments, 2022-2024

Table 137 : Terumo Corp.: Company Snapshot

Table 138 : Terumo Corp.: Financial Performance, FY 2022 and 2023

Table 139 : Terumo Corp.: Product Portfolio

Table 140 : Terumo Corp.: News/Key Developments, 2023 and 2024

Table 141 : Vygon SAS: Company Snapshot

Table 142 : Vygon SAS: Product Portfolio

Table 143 : Wellmed International Industries Pvt. Ltd.: Company Snapshot

Table 144 : Wellmed International Industries Pvt. Ltd.: Product Portfolio

List of Figures

Summary Figure : Global Market for IV Therapy and Venous Access Devices, by Product Type, 2021–2029

Figure 1 : Snapshot of the Market Dynamics for IV Therapy and Venous Access Devices

Figure 2 : Distribution of New Cases of Cancer, by WHO Region, 2022

Figure 3 : Distribution of Cancer Mortality Cases, by WHO Region, 2022

Figure 4 : Global Market Shares of IV Therapy and Venous Access Devices, by Product Type, 2023

Figure 5 : Global Market Shares of IV Solutions and Sets, by Type, 2023

Figure 6 : Global Market Shares of Infusion Pumps, by Type, 2023

Figure 7 : Global Market Shares of Venous Access Devices (IV Catheters), by Type, 2023

Figure 8 : Global Market Shares of IV Therapy and Venous Access, by Application, 2023

Figure 9 : Global Market Shares of IV Therapy and Venous Access Devices, by Region, 2023

Figure 10 : North American Market Shares of IV Therapy and Venous Access, by Country, 2023

Figure 11 : European Market Shares of IV Therapy and Venous Access, by Country, 2023

Figure 12 : Asia-Pacific Market Shares of IV Therapy and Venous Access, by Country, 2023

Figure 13 : 2024 Progress Assessment: Tracking the Sustainable Development Goals

Figure 14 : Patents Documented, by Owner, January 2021 to November 2024

Figure 15 : Share of Patents Documented, by Jurisdiction, January 2021 to November 2024

Figure 16 : Patents Documented Over Time, January 2010 to November 2024

Figure 17 : Leading Companies’ Shares of Global Market for IV Therapy and Venous Access Devices, 2023

Figure 18 : AngioDynamics: Revenue Shares, by Business Unit, FY 2023

Figure 19 : AngioDynamics: Revenue Shares, by Country/Region, FY 2023

Figure 20 : Baxter: Revenue Shares, by Business Unit, FY 2023

Figure 21 : Baxter: Revenue Shares, by Country/Region, FY 2023

Figure 22 : B. Braun SE: Revenue Shares, by Business Unit, FY 2023

Figure 23 : B. Braun SE: Revenue Shares, by Country/Region, FY 2023

Figure 24 : BD: Revenue Shares, by Business Unit, FY 2024

Figure 25 : BD: Revenue Shares, by Country/Region, FY 2024

Figure 26 : Cardinal Health: Revenue Shares, by Business Unit, FY 2023

Figure 27 : Cardinal Health: Revenue Shares, by Country/Region, FY 2023

Figure 28 : Fresenius SE & Co. KGaA: Revenue Shares, by Business Unit, FY 2023

Figure 29 : Fresenius SE & Co. KGaA: Revenue Shares, by Country/Region, FY 2023

Figure 30 : ICU Medical Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 31 : ICU Medical Inc.: Revenue Shares, by Country/Region, FY 2023

Figure 32 : IRadimed Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 33 : IRadimed Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 34 : Medtronic: Revenue Shares, by Business Unit, FY 2023

Figure 35 : Medtronic: Revenue Shares, by Country/Region, FY 2023

Figure 36 : Pfizer Inc.: Revenue Shares, by Business Unit, FY 2023

Figure 37 : Pfizer Inc.: Revenue Shares, by Country/Region, FY 2023

Figure 38 : Terumo Corp.: Revenue Shares, by Business Unit, FY 2023

Figure 39 : Terumo Corp.: Revenue Shares, by Country/Region, FY 2023

Figure 40 : Vygon SAS: Revenue Shares, by Business Unit, FY 2023

BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。

ライセンス別価格表

2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

新価格表

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

旧価格表

旧ライセンスタイプ1

旧ライセンスタイプ2

ご購入に関するご案内

価格・納期について

• 価格
• ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • 2-5ライセンス
    • 同一企業内5名までレポートファイルのご利用が可能です。
  • サイトライセンス
    • 同一企業同住所内でレポートファイルのご利用が可能です。
  • エンタープライズライセンス
    • 同一企業内人数無制限でレポートファイルのご利用が可能です。
• 納品形態
  • Eメール
• 納期
  • ご注文後3営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• バイオプラスチックの世界市場と技術 2025-03-07
• 半導体製造調査レビュー　2024年 2025-03-06
• 製造市場レビュー　2024年 2025-03-05
• 計測器とセンサの調査レビュー　2024年 2025-03-05
• 航空宇宙用先端材料の世界市場 2025-03-05

BCC Research  出版レポート一覧